Abstract:Emerging evidence suggests that GSK3β, a redox-sensitive transducer downstream of insulin signaling, acts as a convergent point for myriad pathways implicated in kidney injury, repair, and regeneration. However, its role in diabetic kidney disease remains controversial. In cultured glomerular podocytes, exposure to a milieu of type 2 diabetes elicited prominent signs of podocyte injury and degeneration, marked by loss of homeostatic marker proteins like synaptopodin, actin cytoskeleton disruption, oxidative stress and apoptosis, and stress-induced premature senescence, as shown by increased staining for senescence-associated β-galactosidase activity, amplified formation of γH2AX foci, and elevated expression of mediators of senescence signaling, like p21 and p16INK4A. These degenerative changes coincided with GSK3β hyperactivity, as evidenced by GSK3β overexpression and reduced inhibitory phosphorylation of GSK3β, and were averted by tideglusib, a highly-selective small molecule inhibitor of GSK3β. In agreement, post-hoc analysis of a publicly-available glomerular transcriptomics dataset from patients with type 2 diabetic nephropathy revealed that the curated diabetic nephropathy-related gene set was enriched in high GSK3β expression group. Mechanistically, GSK3β-modulated nuclear factor Nrf2 signaling is involved in diabetic podocytopathy, because GSK3β knockdown reinforced Nrf2 antioxidant response and suppressed oxidative stress, resulting in an improvement in podocyte injury and senescence. Conversely, ectopic expression of the constitutively active mutant of GSK3β impaired Nrf2 antioxidant response and augmented oxidative stress, culminating in an exacerbated diabetic podocyte injury and senescence. Moreover, IRS-1 was found to be a cognate substrate of GSK3β for phosphorylation at IRS-1S332, which negatively regulates IRS-1 activity. GSK3β hyperactivity promoted IRS-1 phosphorylation, denoting a desensitized insulin signaling. Consistently, in vivo in db/db mice with diabetic nephropathy, GSK3β was hyperactive in glomerular podocytes, associated with IRS-1 hyperphosphorylation, impaired Nrf2 response and premature senescence. Our finding suggests that GSK3β is likely a novel therapeutic target for treating type 2 diabetic glomerular injury.

Conditional ablation of glycogen synthase kinase 3 β in postnatal mouse kidney

The redox sensitive glycogen synthase kinase 3β suppresses the self-protective antioxidant response in podocytes upon oxidative glomerular injury.

The β isoform of GSK3 mediates podocyte autonomous injury in proteinuric glomerulopathy.

Conditional ablation of Gsk-3β in islet beta cells results in expanded mass and resistance to fat feeding-induced diabetes in mice

Genetic and Pharmacologic Targeting of Glycogen Synthase Kinase 3 Beta Reinforces the Nrf2 Antioxidant Defense Against Podocytopathy

The Redox-Sensitive GSK3β is a Key Regulator of Glomerular Podocyte Injury in Type 2 Diabetic Kidney Disease

Redox-Sensitive Glycogen Synthase Kinase 3 Beta-Directed Control Of Mitochondrial Permeability Transition: Rheostatic Regulation Of Acute Kidney Injury

Fine-tuning of NFκB by Glycogen Synthase Kinase 3β Directs the Fate of Glomerular Podocytes Upon Injury.

PKB/SGK-Resistant GSK-3 Signaling Following Unilateral Ureteral Obstruction

Deletion of Glycogen Synthase Kinase 3 Beta Reprograms NK Cell Metabolism

Long-term Renal Changes in the Liver-Specific Glucokinase Knockout Mouse: Implications for Renal Disease in Maturity-Onset Diabetes of the Young 2

Differential Expression of Genes Associated with the Progression of Renal Disease in the Kidneys of Liver-Specific Glucokinase Gene Knockout Mice

Mechanism of Kinase Inactivation and Nonbinding of FRATide to GSK3β Due to K85M Mutation: Molecular Dynamics Simulation and Normal Mode Analysis.

GSK-3α is a central regulator of age-related pathologies in mice

Glycogen Synthase Kinase 3β Orchestrates Microtubule Remodeling in Compensatory Glomerular Adaptation to Podocyte Depletion.

Inhibition of Glycogen Synthase Kinase 3β Alleviates Chronic Renal Allograft Dysfunction in Rats

Microsecond Molecular Dynamics Simulations and Dynamic Network Analysis Provide Understanding of the Allosteric Inactivation of GSK3β Induced by the L343R Mutation

Permissive Effect of GSK3β on Profibrogenic Plasticity of Renal Tubular Cells in Progressive Chronic Kidney Disease.

Characterization of the Gene Expression Profile of Heterozygous Liver-Specific Glucokinase Knockout Mice at A Young Age

The age-associated decline of glycogen synthase kinase 3beta plays a critical role in the inhibition of liver regeneration

Glycogen synthase kinase 3β hyperactivity in urinary exfoliated cells predicts progression of diabetic kidney disease